Morning
8:30 am
Arrival & Welcome Coffee
9:15 am
Andrew Deans SVI
An introduction to the challenges and opportunities of gene editing in blood
9:30 am
Tracy Bryan CMRI
High efficiency HDR-based editing of a telomerase gene
10:00 am
Luke Chan Monash
Reactivation of δ-globin via CRISPR/Cas12a to treat β-haemoglobinopathies
10:20 am
Flash Talks — Session 1
10:30 am
Coffee Break & Networking
11:05 am
Lorna McLeman MCRI
Clinical/regulatory pathways: lessons learned from SCID gene therapy
11:25 am
Kirsten Fairfax U. Tas
Exploring the efficiency of single base editors for small libraries of variants implicated in Bone Marrow Failure Syndromes
11:45 am
Astrid Glaser SVI
Prime editing of mouse and human HSCs
12:05 pm
Angus Johnston MIPS
Optimisation of LNP targeting by controlling orientation of the targeting ligand
12:25 pm
Flash Talks — Session 2
12:40 pm
Lunch Break
Afternoon
1:45 pm
Elizabeth Ng MCRI
Growing and editing HSCs from iPSC
2:15 pm
Shalin Naik WEHI
Towards a streamlined diagnostic and therapeutic for rare monogenic blood and immune disorders
2:35 pm
Catherine Carmichael Hudson
Generating physiologically relevant cellular models of paediatric AML using CRISPR/Cas9 in CD34+ cord blood stem cells
2:55 pm
Marco Herold ONJ
Using CRISPR technology to discover cancer drivers and therapeutic resistance factors in lymphoma
3:15 pm
Afternoon Tea
3:35 pm
Tom Lew WEHI
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression
3:55 pm
Christina Koenig ONJ
Using cutting edge CRISPR base editor technology to explore development of lymphoma
4:15 pm
Wrap-Up Discussions
4:35 pm
Finish
Gene editing in blood & immunity 